- Home
- INBK vs LUNG Comparison
INBK vs LUNG Comparison
Compare INBK & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- LUNG
- Stock Information
- Founded
- INBK 1999
- LUNG 1995
- Country
- INBK United States
- LUNG United States
- Employees
- INBK N/A
- LUNG N/A
- Industry
- INBK Major Banks
- LUNG Industrial Specialties
- Sector
- INBK Finance
- LUNG Health Care
- Exchange
- INBK Nasdaq
- LUNG Nasdaq
- Market Cap
- INBK 289.7M
- LUNG 256.3M
- IPO Year
- INBK N/A
- LUNG 2020
- Fundamental
- Price
- INBK $30.39
- LUNG $8.96
- Analyst Decision
- INBK Buy
- LUNG Buy
- Analyst Count
- INBK 3
- LUNG 6
- Target Price
- INBK $41.00
- LUNG $11.92
- AVG Volume (30 Days)
- INBK 33.3K
- LUNG 392.8K
- Earning Date
- INBK 01-22-2025
- LUNG 02-19-2025
- Dividend Yield
- INBK 0.79%
- LUNG N/A
- EPS Growth
- INBK 203.16
- LUNG N/A
- EPS
- INBK 2.88
- LUNG N/A
- Revenue
- INBK $117,652,000.00
- LUNG $83,789,000.00
- Revenue This Year
- INBK N/A
- LUNG $22.26
- Revenue Next Year
- INBK $19.61
- LUNG $18.72
- P/E Ratio
- INBK $10.55
- LUNG N/A
- Revenue Growth
- INBK 39.44
- LUNG 22.01
- 52 Week Low
- INBK $24.18
- LUNG $5.46
- 52 Week High
- INBK $43.26
- LUNG $11.73
- Technical
- Relative Strength Index (RSI)
- INBK 31.34
- LUNG 75.17
- Support Level
- INBK $31.08
- LUNG $6.50
- Resistance Level
- INBK $33.72
- LUNG $9.37
- Average True Range (ATR)
- INBK 1.21
- LUNG 0.54
- MACD
- INBK -0.10
- LUNG 0.26
- Stochastic Oscillator
- INBK 0.00
- LUNG 89.21
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking/treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.